1. Home
  2. WTM vs BLCO Comparison

WTM vs BLCO Comparison

Compare WTM & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTM
  • BLCO
  • Stock Information
  • Founded
  • WTM 1980
  • BLCO 1853
  • Country
  • WTM Bermuda
  • BLCO Canada
  • Employees
  • WTM N/A
  • BLCO N/A
  • Industry
  • WTM Property-Casualty Insurers
  • BLCO Ophthalmic Goods
  • Sector
  • WTM Finance
  • BLCO Health Care
  • Exchange
  • WTM Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • WTM 4.6B
  • BLCO 4.9B
  • IPO Year
  • WTM N/A
  • BLCO 2022
  • Fundamental
  • Price
  • WTM $1,786.55
  • BLCO $14.32
  • Analyst Decision
  • WTM
  • BLCO Hold
  • Analyst Count
  • WTM 0
  • BLCO 12
  • Target Price
  • WTM N/A
  • BLCO $15.55
  • AVG Volume (30 Days)
  • WTM 26.5K
  • BLCO 805.4K
  • Earning Date
  • WTM 08-06-2025
  • BLCO 07-30-2025
  • Dividend Yield
  • WTM 0.06%
  • BLCO N/A
  • EPS Growth
  • WTM N/A
  • BLCO N/A
  • EPS
  • WTM 10.73
  • BLCO N/A
  • Revenue
  • WTM $2,284,800,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • WTM N/A
  • BLCO $6.99
  • Revenue Next Year
  • WTM N/A
  • BLCO $5.46
  • P/E Ratio
  • WTM $165.77
  • BLCO N/A
  • Revenue Growth
  • WTM 0.12
  • BLCO 11.94
  • 52 Week Low
  • WTM $1,666.22
  • BLCO $10.45
  • 52 Week High
  • WTM $2,023.00
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • WTM 49.35
  • BLCO 64.48
  • Support Level
  • WTM $1,777.88
  • BLCO $13.89
  • Resistance Level
  • WTM $1,824.80
  • BLCO $14.49
  • Average True Range (ATR)
  • WTM 23.95
  • BLCO 0.39
  • MACD
  • WTM -1.83
  • BLCO -0.02
  • Stochastic Oscillator
  • WTM 26.45
  • BLCO 80.92

About WTM White Mountains Insurance Group Ltd.

White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: